Member Info for Tornadotony

https://www.thinkmarkets.com/en/learn-to-trade/indicators-and-patterns/bullish-patterns/falling-wedge-pattern/

Also view the weekly chart. It suggests this play out over the month of October.

As mentioned in the article the 1/3 pull back is 13.75p and 14p buy. This is the deepest it can go and so handle could be less like 14p and 14.25p buy.

https://www.ig.com/en/trading-strategies/cup-and-handle-chart-pattern-explained-190930

The cup is complete and its trading down a bit to give the handle. Nothing to worry about. In fact its a good thing.

Expecting this to drop to 14.5p.

The TR1 should put a floor in.

Precisely DP and that is why the UK Government has to make its mind up on what it will do with Pensana in Saltend.

Can add more if it retreats.

The last share to go short on is this one. Brilliant time to do some averaging down.

Just imagine if the UK Government rips off the Angola Government and the Angolan people by not seriously supporting Saltend development. The Angolans would say to the rest of Africa do not deals with the BJ administration go for USA, EU who will actually do something.

If Saltend does not get built who wants to build EV cars in Brexit Britain, who wants to have an aerospace defense industry or advanced communications industries and no silicon type valley company as they all try to get hold of essential resources to import. No chance, they would all move to EU and get tons of subsidised help in the process.

Following of from stupidity. A paper for those who may not have come across it.

http://harmful.cat-v.org/people/basic-laws-of-human-stupidity/?fbclid=IwAR0CX4YjP2AM_fZhgMBlNS7dg-g-ROyFDkul_Snrr8AGdP6VeACfKBbVVQU

goldforefinger

I agree. It is simply resetting on to the new projected trial completion date. I am fairly confident it will be in the 140's by the end of the month or early November and slowly moving higher as before. Tony

Andy

Nothing is certain. The only thing we know it has switched out of oversold and tested the long standing support line at 121p this morning. I will not be surprised if that support line gets retested later in the week. For all we know it could be a dead cat bounce that gets sold into. Its a coin toss what happens this afternoon. A lot of companies that deliver delayed phase 3 trials RNS get sold into for a week or two before they go back up.

Resistance lines in the chart are at;

15.6p, 15.8p and 16.15p and together that is tough barrier to breakthrough.

The support line is on 14.85p and a second support line is at 14.65 and they are not particularly strong. The strongest support line is at 13.75p sell and 14p buy where the 38.2% Fib line sits. Given time the FIB line improves. For those who use charts its not meaningless to us.

Tony

Not surprising really. We may need to see a 10% pull back to advance to 16.5p kind of move. Resistance is very strong around the 15p to 15.5p level and it has struggled at this point in the past. It would still be a bullish chart pattern if it happened.

Long term support so far has held.

In the de-risked zone.

Front End Engineering Design or FEED is an engineering design approach adopted prior to detailed engineering, procurement, and construction. It is an important engineering design phase that is used to control project expenses and thoroughly plan a project before bid submission. Benchmark studies have shown that FEED constitutes roughly 2% of the project cost but properly executed FEED projects can reduce up to 30% of costs during design and execution. Front-end engineering design is a basic engineering phase conducted after conceptual design or feasibility study. FEED is also known as Front End Loading or Front End Engineering.

They are beyond the feasibility study.

DP

As the company fully explained before and many others have done so on LSE, they are required to do a front end engineering deposition or whatever its called FEED. This process incorporates far more than a BFS and the work will be fully complete in 4 weeks time. The costings provided on FEED are far more rigorous and they incorporate both Saltend and the mine together and banks require a FEED analysis above the BFS. Prior to FEED they will have both the ATF contribution if any being known and they will know the percentage above libor they have to pay for the debt. In addition off takers will give an idea of what they will pay for various quantities of materials but this will be further down stream, but should not stop both projects commencing with construction in early 2022. If the project was just a mine in Angola only than a BFS model would have applied.

DP what ever you think or say here is not going to change the view of Pensana investors on the desire to have a UK based rare earth oxide producer. A lot of industries will quit the UK if it is not created as the supply chain import headaches is not what other sectors will put up with. Peak up the road has yet to establish a secure feedstock supply where as Pensana has already secured 14 years that will soon be extend to around 21 years on COOLA exploration. Saltend is also a far bigger project and only meets UK needs and a little spare for EU. Peak is a second source for additional supply chain security to arrive at the same time or just after Pensana. Rainbow and MKA are supplying other global markets like Lynas.

Academia were dropped of late for over promising on the delivery. The CEO will need a risk manager, logistics honest person who says how it is and what needs to be done if they are not there already (the kind of person who wanders around with tons of spreadsheets and has answers for every paranoia of what can go wrong and they won't be academic like on how they do it). As wonderful as academia were in having the brilliance of creating where this all got to, the commercial world has to operate on teams of people, with a much broader focus and skill sets. Knowing when to defer to the person fronting with all the different stakeholders may take some adjusting,but it reflects a greater transparency and maturity in the company by delivering such changes. The ethos going forward should be under promise and over deliver on positive surprise from now on if at all possible.

Synairgen will recover from the share price shake down and many will see it as an opportunity to jump in late stage as its 80% de-risked on a number of fronts. It always had competition, but that the idea that one therapy in the hospital tool box would solve everything is far fetched and we just have to look at supply line fiascos all around us to know that several therapies are going to be needed. At least Synairgen won't need glass. In the meantime I wonder if a company like Sanofi might be knocking on CEOs door fairly soon. They gave up on the vaccine on 29th September as it was to late for market entry. Just maybe they will not want to be late on therapies and want first shout on a deal and bring in their resources to get this all over the line. The CEO may be very busy, but a non-hostile alliance is something he may well make time for.

In the meantime, I can occasionally share chart stuff as traders use them as tools, but will keep it brief when I do know a lot of readers have mixed views on them. I remain confident that a good result will emerge from all of this. It could well be that big bulk buy to help keep COPD, influenza and some Covid 19 patients out of hospital and allowing healthcare to run more effectively in the winter months is economically sensible to do. It needs to be that way if there is any hope of catching up on care provision which gets more expensive on greater delays. An unhealthy nation as we all know is a poor one and our best wealth is having good health.
Tony